FDA Import Refusal 112-8043509-9/1/1 — Glaxo Smith Kline Phils Inc
The FDA refused shipment 112-8043509-9/1/1 from Glaxo Smith Kline Phils Inc (Philippines) on Dec 12, 2005. The refused product falls under Drugs and Biologics — ANTI-HYPERTENSIVE N.E.C.. Cited charge: 118 This firm has 1 other import refusal on record.
Refusal details
- Date
- Dec 12, 2005
- Country
- Philippines
- Product Category
- Drugs and Biologics
- Product Code
- 62CCC99 ANTI-HYPERTENSIVE N.E.C.
- Charges
- 118